CLASS II Device recall · Reported 12 Dec 2018 · FDA Enforcement Report

Cascade Abrazo c-Act-lr Test Card Ivd For IN Vitro recalled

Helena Laboratories is recalling Cascade Abrazo c-Act-lr Test Card Ivd For IN Vitro Diagnostic Use Store at 2 to 8 C, distributed nationwide in the US. The recall was initiated on 24 Feb 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Codes: 1-16-5701 Model/Catalog Number: 5701
Quantity recalled27 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0561-2019
FDA event ID
81378
Recalling firm
Helena Laboratories, Beaumont, TX
Classification
Class II
Status
Terminated
Recall initiated
24 Feb 2017
FDA classified
6 Dec 2018
Reported
12 Dec 2018
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

24 Feb 2017Recall initiated by company
6 Dec 2018Classified by FDA+650 days
12 Dec 2018Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due to some cards in this lot reported to have experienced variations in results, (verified by wave form), resulting in some cards with shorter or longer times than expected.

Product as listed by the FDA

Cascade Abrazo c-ACT-LR Test Card IVD FOR IN VITRO DIAGNOSTIC USE Store at 2 to 8 C HELENA LABORATORIES 003366 12/13(2) FOR EXPORT ONLY

Where it was distributed

US: Products under control of Manufacturer in TX OUS: Four International Distributors - Australia, Netherlands, Italy, and England

Nationwide Texas

Questions about this recall

Is Cascade Abrazo c-Act-lr Test Card Ivd For IN Vitro Diagnostic Use Store at 2 to 8 C recalled?

Yes. Helena Laboratories recalled Cascade Abrazo c-Act-lr Test Card Ivd For IN Vitro Diagnostic Use Store at 2 to 8 C on 24 Feb 2017. The recall is Class II and its status is Terminated. Recall number Z-0561-2019.

Why was it recalled?

Due to some cards in this lot reported to have experienced variations in results, (verified by wave form), resulting in some cards with shorter or longer times than expected.

Which lots are affected?

Lot Codes: 1-16-5701 Model/Catalog Number: 5701

Where was it sold?

US: Products under control of Manufacturer in TX OUS: Four International Distributors - Australia, Netherlands, Italy, and England

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Helena Laboratories

All 16

Other Test Kits & Diagnostics recalls

All 2,656